| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.009 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |